Organ-on-a-chip devices are powerful modeling systems that allow researchers to
recapitulate the in vivo structures of organs as well as the physiological conditions those …

Angiogenesis, the development of new blood vessels from pre-existing ones, is an essential
process determining numerous physiological and pathological conditions. Accordingly …

Glioblastoma is a difficult-to-cure disease owing to its malignancy. Under normal
circumstances, cancer is dependent on the glycolytic system for growth, and mitochondrial …

Angiogenic factors associated with Moyamoya disease (MMD) are overexpressed in M2
polarized microglia in ischemic stroke, suggesting that microglia may be involved in the …

Arginine methylation is a post-translational modification that consists of the transfer of one or
two methyl (CH3) groups to arginine residues in proteins. Several types of arginine …

Angiogenesis is the development of new blood vessels from pre-existing vasculature.
Multiple factors control its course. Disorders of the distribution of angiogenic agents are …

Background: Vascular co-option is one of the main features of brain tumor progression. It is
identified using histopathological analysis, but no antibody-specific markers were found, and …

Biochemical and biophysical cues governing glioblastoma (GBM) progression are complex
and dynamic. Tumor blood vessels, often recognized only by their transport functions, are …

The conception of vascularized organ-on-a-chip models provides researchers with the
ability to supply controlled biological and physical cues that simulate the in vivo dynamic …

Glioblastoma multiforme (GBM) is the deadliest form of brain cancer, responsible for over
50% of adult brain tumors. A specific region within the GBM environment is known as the …